Corventis Announces Joint Participation with Ericsson at CANTO 2009 in Trinidad and Tobago

Technologies to Demonstrate Delivery of Wireless Cardiovascular Care to Patients
Globally

SAN JOSE, Calif.--(Business Wire)--
Corventis, Inc., a developer of wireless cardiovascular solutions designed to
enable early detection, prevention and treatment of cardiovascular conditions,
announced today that it will be jointly presenting and participating with
Ericsson at CANTO 2009 on Wednesday, July 15th at 8:30 AM (5:30 AM PST) during
the `HSPA and LTE and Beyond Session` in the Jade ballroom at the Hyatt Regency
Trinidad. The companies will be demonstrating a potential solution designed to
provide wireless health management capabilities to clinicians and patients
located in urban and remote areas.

Corventis` wireless cardiovascular platform technology has been designed to
deliver focused visibility into the cardiac health status of patients by
combining patient-friendly wearable sensors with advanced computational
algorithms, global wireless capabilities and a comprehensive web- based
infrastructure. The system provides clinicians actionable information on an
exception basis to help diagnose potential health risks, including non-lethal
arrhythmias, from anywhere across the globe.

By aligning with the CANTO 2009 theme of `Advancing the Caribbean through
Information and Communication`, the joint effort with Ericsson aims to
demonstrate how emerging telecommunications technologies can further expand the
delivery of innovative healthcare solutions to clinicians and patients in the
Caribbean and beyond.

About Corventis Technology

Electrocardiograms (ECG) and other tests performed in a hospital or clinic
setting provide valuable information about the rhythm of the heart and overall
patient health status. In many cases, however, it is necessary to monitor heart
rhythm or other physiological signals for a longer period of time for a better
understanding of the patient`s condition.

The elegant PiiX wearable sensor from Corventis enables continuous monitoring
for ambulatory patients - providing clinicians with insight into patient
cardiovascular health during normal daily routines. The PiiX sensor
automatically collects physiological information and wirelessly transmits the
data from the patient to Corventis for further analysis and presentation on a
secure website.

With no cumbersome leads and wires, the patient-friendly design of PiiX
encourages continuous wear, even while showering or sleeping. Fully automated
collection and transmission of data also minimizes the number of steps required
by the patient to ensure reliable event detection.

For physicians, Corventis wireless technology offers ongoing visibility into a
patient`s cardiac health status previously accessible mainly with invasive
implantable devices. Multiple sensors on the PiiX enable intelligent detection
of clinical events and the creation of comprehensive heart rate, respiratory
rate, fluid status, posture and activity trends. Clinical event information such
as ECG is captured on an exception basis, enabling focused review and diagnosis
by clinicians.

About Corventis

Corventis, Inc. is a pioneer in wireless cardiovascular solutions. The company`s
technology enables global personalized patient care by providing clinicians with
actionable diagnoses for early detection, prevention and treatment.Corventis is
funded by prominent venture capital firms Kleiner, Perkins, Caufield & Byers,
Mohr Davidow Ventures and DAG Ventures. Privately held, the company is located
in San Jose, Calif. For more information visit www.corventis.com.

Feinstein Kean Healthcare for Corventis
Jeremiah Hall, 415-519-0207
jeremiah.hall@fkhealth.com

Copyright Business Wire 2009